References
- Gorrell M. D., Gysbers V., McCaughan G. W. CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes. Scand J Immunol 2001; 54: 249–64
- Tanaka T., Duke‐Cohan J. S., Kameoka J., Yaron A., Lee I., Schlossman S. F., et al. Enhancement of antigen‐induced T‐cell proliferation by soluble CD26/dipeptidyl peptidase IV. Proc Natl Acad Sci USA 1994; 91: 3082–6
- Seitzer U., Scheel‐Toellner D., Mattern T., Haas H., Flad H. D., et al. Staining pattern of seven monoclonal anti‐CD26 antibodies in leprosy: implications for the use of CD26 as a surrogate marker of a human Th1‐like reaction. Virchows Arch 1998; 432: 343–7
- Proost P., Schutyser E., Menten P., Struyf S., Wuyts A., Opdenakker G., et al. Amino‐terminal truncation of CXCR3 agonists impairs receptor signalling and lymphocyte chemotaxis while preserving antiangiogenic properties. Blood 2001; 98: 3554–61
- Wrenger S., Faust J., Friedrich D., Hoffman T., Hartig R., Lendeckel U., et al. Attractin, a dipeptidyl peptidase IV/CD26‐like enzyme, is expressed on human peripheral blood monocytes and potentially influences monocyte function. J Leukoc Biol 2006; 80: 621–9
- Ohnuma K., Inoue H., Uchiyama M., Yamochi T., Hosono O., Dang N. H., et al. T‐cell activation via CD26 and caveolin‐1 in rheumatoid synovium. Mod Rheumatol 2006; 16: 3–13
- Ellingsen T., Hornng N., Møller B. K., Hjelm Poulsen J., Stengaard‐Pedersen K. In active chronic rheumatoid arthritis, dipeptidyl peptidase IV (DPPIV; CD26) density is increased on monocytes and CD4+ T lymphocytes. Scand J Immunol, doi:10.1111/j.1365‐3083.2007.01966.x
- Ellingsen T., Hornung N., Moller B. K., Poulsen J. H., Stengaard‐Pedersen K. Differential effect of methotrexate on the increased CCR2 density on circulating CD4+ T‐lymphocytes in active chronic rheumatoid arthritis, with a down regulation only on monocytes in responders. Ann Rheum Dis 2006; 66: 151–7
- Brezinschek R. I., Lipsky P. E., Galea P., Vita R., Oppenheimer Marks N. Phenotypic characterization of CD4+ T cells that exhibit a transendothelial migratory capacity. J Immunol 1995; 154: 3062–77
- Yamasaki S., Ueki Y., Nakamura H., Yano M., Matsumoto K., Miyake S., et al. Effect of filtration leukocytapheresis therapy: modulation of white blood cell enzyme activities in patients with rheumatoid arthritis. Artif Organs 2002; 26: 378–84